BEI
CLLS

Benjamin Edwards Inc’s Cellectis CLLS Stock Holding History

Benjamin Edwards Inc’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-566
Closed -$15K – 376
2020
Q4 		$15K Sell
566
-172
-23% -$3.86K 0.01% 309
2020
Q3 		$14K Sell
738
-12
-2% -$213 0.01% 297
2020
Q2 		$13K Buy
750
+275
+58% +$4.18K 0.01% 279
2020
Q1 		$4K Buy
475
+22
+5% +$328 ﹤0.01% 334
2019
Q4 		$8K Buy
453
+12
+3% +$160 0.02% 235
2019
Q3 		$5K Sell
441
-4
-0.9% -$54 0.01% 252
2019
Q2 		$7K Buy
445
+150
+51% +$2.68K 0.02% 239
2019
Q1 		$5K Buy
+295
New +$5.23K 0.02% 243

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIA
Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

Benjamin Edwards Inc's CLLS Position: Q1 2021 in Review

Benjamin Edwards Inc sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 566 shares — an estimated $15K sold.

Benjamin Edwards Inc first reported a position in CLLS in Q1 2019 and held it in 8 quarters. The position peaked at $15K in Q4 2020. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • Benjamin Edwards Inc reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • Benjamin Edwards Inc sold 566 Cellectis shares in Q1 2021, an estimated $15K.
  • Benjamin Edwards Inc first reported a position in Cellectis in Q1 2019 and held it in 8 quarters.
  • Benjamin Edwards Inc's Cellectis position peaked at $15K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Benjamin Edwards Inc's 13F filing for Q1 2021, filed 14 May 2021.